Artificial Intelligence 2022 - FDA Regulations for Artificial Intelligence / Machine Learning
Date2022-03-10
Deadline2022-03-09
VenueOnline, Online
KeywordsFDA Compliance; Machine Learning; Artificial Intelligence
Topics/Call fo Papers
FDA Regulations and Requirements for Artificial Intelligence / Machine Learning
Product Id : FDB3356
Category : Clinical & Laboratory, FDA Compliance, Food, Drugs & Biologics, Information Technology, Medical Devices
Presenter : José Mora
Scheduled On : March 10 2022 1:00 pm
US/Canada (Eastern Time - ET)
Duration : 60 Minutes
AI/ML will revolutionize medicine by making diagnosis and treatment more accessible and more effective. FDA has regulated medical software by means of regulation and guidance for years, however, AI/ML programs fall outside the scope of these regulations and guidance. This happens because the FDA approves the final, validated version of the software. The point of AI/ML is to learn and update the following deployment to improve performance. Thus the field version of the software is no longer the validated approved version.
We will discuss the current regulatory requirements, how they don’t control AI/ML adequately, and approaches FDA is considering for regulation in the near future. Your development program should conform to these concepts now because, with some modifications, they will probably become regulations. Following a discussion of possible future regulations, we will discuss, based on recently approved De Novo applications, how to get your AI/ML program approved now. Necessary submission documentation will be explained. This webinar is not a programming course but will explain the present and future regulatory requirements for AI/ML
Why You Should Attend:
It is not clear how to get AI/ML programs approved. The current regulatory requirements don’t control AI/ML adequately. We will discuss the approaches FDA is considering for regulation in the near future and how to get your AI/ML program approved by the FDA now. Necessary submission documentation will be explained. Attendees will receive a multipage outline and checklist.
Areas Covered in the Session :
Required number of participants
Qualitative success criteria
Choice of tasks to validate
Post-test participant inquiry. Forms: Usability Validation Tracking Matrix
Validation Protocol
Validation Test Results Report will be given as Handouts
Who Should Attend:
Quality Assurance Departments
Research and Development Departments
Regulatory Affairs Departments
Engineering Departments
Software Engineers
Marketing Departments
IT Departments
Management Teams
Please click on the following link to Register
https://www.webinarcompliance.com/product/fda-regu...
Product Id : FDB3356
Category : Clinical & Laboratory, FDA Compliance, Food, Drugs & Biologics, Information Technology, Medical Devices
Presenter : José Mora
Scheduled On : March 10 2022 1:00 pm
US/Canada (Eastern Time - ET)
Duration : 60 Minutes
AI/ML will revolutionize medicine by making diagnosis and treatment more accessible and more effective. FDA has regulated medical software by means of regulation and guidance for years, however, AI/ML programs fall outside the scope of these regulations and guidance. This happens because the FDA approves the final, validated version of the software. The point of AI/ML is to learn and update the following deployment to improve performance. Thus the field version of the software is no longer the validated approved version.
We will discuss the current regulatory requirements, how they don’t control AI/ML adequately, and approaches FDA is considering for regulation in the near future. Your development program should conform to these concepts now because, with some modifications, they will probably become regulations. Following a discussion of possible future regulations, we will discuss, based on recently approved De Novo applications, how to get your AI/ML program approved now. Necessary submission documentation will be explained. This webinar is not a programming course but will explain the present and future regulatory requirements for AI/ML
Why You Should Attend:
It is not clear how to get AI/ML programs approved. The current regulatory requirements don’t control AI/ML adequately. We will discuss the approaches FDA is considering for regulation in the near future and how to get your AI/ML program approved by the FDA now. Necessary submission documentation will be explained. Attendees will receive a multipage outline and checklist.
Areas Covered in the Session :
Required number of participants
Qualitative success criteria
Choice of tasks to validate
Post-test participant inquiry. Forms: Usability Validation Tracking Matrix
Validation Protocol
Validation Test Results Report will be given as Handouts
Who Should Attend:
Quality Assurance Departments
Research and Development Departments
Regulatory Affairs Departments
Engineering Departments
Software Engineers
Marketing Departments
IT Departments
Management Teams
Please click on the following link to Register
https://www.webinarcompliance.com/product/fda-regu...
Other CFPs
- 3-Hour Virtual Seminar on Computer System Validation (CSV) vs Computer Software Assurance (CSA)
- 2nd World Congress on Advanced Materials and Nanotechnology
- 9th International Conference on Natural, Traditional & Alternative Medicine
- HR Metrics & Analytics 2022: Update on Strategic Planning, Application Activities, and Operational Impact
- Nurse to Nurse Bullying: A Sepsis in Healthcare
Last modified: 2022-02-18 21:26:33